XLV vs XBI.
Health Care Select Sector SPDR Fund (S&P 500 health-care sector) against SPDR S&P Biotech ETF (S&P Biotechnology Select Industry) — fees, long-horizon total returns, holdings overlap, and sector tilt, side by side.
| XLV | XBI | SPREAD | |
|---|---|---|---|
| YTD (cumulative) | +5.41% | +24.8% | -19.37 pp |
| 1Y CAGR | +22.6% | +73.9% | -51.30 pp |
| 3Y CAGR | +8.89% | +21.9% | -12.97 pp |
| 5Y CAGR | +6.41% | +3.97% | +2.44 pp |
| 10Y CAGR | +9.95% | +10.4% | -0.49 pp |
| Since inception CAGR | +8.58% | +11.8% | -3.23 pp |
Total return: dividend- and split-adjusted daily closes (distributions reinvested). Spread is XLV minus XBI. XLV since-inception measured from first available bar December 22, 1998. XBI since-inception measured from first available bar February 6, 2006. Since-inception spans differ — compare that row with care.
| XLV | XBI | |
|---|---|---|
| Name | State Street Health Care Select Sector SPDR ETF | State Street SPDR S&P Biotech ETF |
| Category | Health | Health |
| Style | Passive | Passive |
| Expense ratio | 0.08% | 0.35% |
| Assets (AUM) | $40.6B | $10.7B |
| Dividend yield | 1.60% | 0.36% |
| Avg volume (3-mo) | 10.5M | 8.9M |
| Inception | December 16, 1998 | January 31, 2006 |
| Benchmark proxy | S&P 500 | S&P 500 |
XLV costs 0.27 pp less per year — about $27.00 per $10,000 invested.
Sum of min(weight in each fund) across shared tickers — the standard fund-overlap measure. Computed on the top 25 holdings each fund reports, so it is a lower bound; the coverage figures show how much of each fund those top holdings represent.